Investors have long tracked the grey market premium (GMP) of unlisted shares ahead of an initial public offering (IPO) as a proxy for market sentiment. A strong GMP is generally interpreted as a sign of robust investor interest and is often used to estimate the premium at which a stock could list on the exchanges.
However, recent IPO listings suggest that the GMP may not always provide an accurate picture of how a stock will actually perform on debut.
